Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Neurotrophin receptor p75NTR mediates Huntington’s disease–associated synaptic and memory dysfunction
Verónica Brito, … , Jordi Alberch, Sílvia Ginés
Verónica Brito, … , Jordi Alberch, Sílvia Ginés
Published September 2, 2014
Citation Information: J Clin Invest. 2014;124(10):4411-4428. https://doi.org/10.1172/JCI74809.
View: Text | PDF
Research Article Neuroscience Article has an altmetric score of 13

Neurotrophin receptor p75NTR mediates Huntington’s disease–associated synaptic and memory dysfunction

  • Text
  • PDF
Abstract

Learning and memory deficits are early clinical manifestations of Huntington’s disease (HD). These cognitive impairments have been mainly associated with frontostriatal HD pathology; however, compelling evidence provided by several HD murine models suggests that the hippocampus may contribute to synaptic deficits and memory dysfunction in HD. The neurotrophin receptor p75NTR negatively regulates spine density, which is associated with learning and memory; therefore, we explored whether disturbed p75NTR function in the hippocampus could contribute to synaptic dysfunction and memory deficits in HD. Here, we determined that levels of p75NTR are markedly increased in the hippocampus of 2 distinct mouse models of HD and in HD patients. Normalization of p75NTR levels in HD mutant mice heterozygous for p75NTR prevented memory and synaptic plasticity deficits and ameliorated dendritic spine abnormalities, likely through normalization of the activity of the GTPase RhoA. Moreover, viral-mediated overexpression of p75NTR in the hippocampus of WT mice reproduced HD learning and memory deficits, while knockdown of p75NTR in the hippocampus of HD mice prevented cognitive decline. Together, these findings provide evidence of hippocampus-associated memory deficits in HD and demonstrate that p75NTR mediates synaptic, learning, and memory dysfunction in HD.

Authors

Verónica Brito, Albert Giralt, Lilian Enriquez-Barreto, Mar Puigdellívol, Nuria Suelves, Alfonsa Zamora-Moratalla, Jesús J. Ballesteros, Eduardo D. Martín, Nuria Dominguez-Iturza, Miguel Morales, Jordi Alberch, Sílvia Ginés

×

Figure 9

Intrahippocampal infusion of AAV-shp75 in KI mice at 6 months restores spatial, recognition, and associative memories.

Options: View larger image (or click on image) Download as PowerPoint
Intrahippocampal infusion of AAV-shp75 in KI mice at 6 months restores s...
(A) Western blot showing a significant reduction in p75NTR levels in total hippocampus extracts from AAV-shp75–injected KI mice (n = 8 per genotype). **P < 0.01 compared with WT mice, #P < 0.05 compared with AAV-ctl mice. (B) Percentage of time spent in arms from AAV-ctl and AAV-shp75 mice (n = 8–12 per genotype). AAV-shp75 mice exhibit preference for a previously unexposed arm of a T-maze. (n = 8 per genotype.) #P < 0.05 compared with AAV-ctl mice. (C) Percentage of time exploring the new object location (A2) from AAV-ctl and AAV-shp75 mice in the novel-object location task (n = 7–8 per genotype). AAV-shp75 mice showed significantly greater preference for the novel-object location. ##P < 0.01 compared with AAV-ctl mice, *P < 0.05 compared with familiar object location. (D) Percentage of nose pokes to the new object from AAV-ctl and AAV-shp75 mice in the NORT (n = 8 per genotype). AAV-shp75 mice display preference for the novel object. ##P < 0.01 compared with AAV-ctl mice. (E) Latency to step-through from light to dark compartment from AAV-ctl and AAV-shp75 (n = 8 per genotype). AAV-shp75 mice exhibit more latency to crossover than AAV-ctl. #P < 0.05 compared with AAV-ctl mice. All histograms represent mean ± SEM. Student’s 2-tailed t test was performed in A, D, and E and 1-way ANOVA with Bonferroni post hoc comparisons was performed in B and C.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 1 news outlets
Posted by 1 X users
Referenced in 1 patents
On 2 Facebook pages
Referenced in 1 Wikipedia pages
139 readers on Mendeley
See more details